November 2019 - Page 4 of 6 - CannabisNewsWire

WednesdayNov 13, 2019 4:20 pm

420 with CNW – Clinical Trials of Cannabis as a Treatment for Pancreatic Cancer Expected

The United States Food and Drug Administration has granted a flavonoid of cannabis (Caflanone) the status of the Orphan Drug. It is estimated that within the next few months, the approved Orphan Drug will be used in clinical trials for treating pancreatic cancer. The clinical trials will involve human subjects. Flavocure is a drug innovation and development company. The company developed the cannabis flavonoid Caflanone (FBL-03G). The U.S. Food and Drug Administration granted Caflanone the Orphan drug status after it was successful in reducing tumor progression in animals with pancreatic cancer through therapy. The Executive Chairman of Flavocure, Dr. Henry…

WednesdayNov 13, 2019 11:23 am

MCTC Holdings Inc. (MCTC) is “One to Watch”

Achieving considerable progress in the research and development of new products utilizing its innovative cannabinoid delivery systems In the process of introducing several cannabinoid consumer products based on the company’s internally developed high bioavailability infusion technologies Highly experienced management team with significant participation in the cannabis and hemp industries IP portfolio includes four patents on the company’s cannabinoid delivery technology systems MCTC Holdings Inc. (OTC: MCTC) is an innovator in the field of cannabinoid nanoparticles and infusion technologies with several important cannabinoid patents filed and an active research and development program underway. The company was reorganized during June of 2019…

WednesdayNov 13, 2019 4:20 am

420 with CNW – Yale Teams Up With Weed Company to Study Effects of Cannabis on Stress

The Yale School of Medicine and CT Pharmaceuticals Solutions Inc. have teamed up to conduct a study on the impact of medical marijuana on stress and mental health. On Friday, Yale and CT Pharmaceuticals announced that they would be conducting a phase-one study on the effects of a variety of cannabis strains with medicinal qualities for alleviating pain and stress. They will also examine other conditions such as PTSD (post-traumatic stress disorder), and opioid replacement. This is a revolutionary clinical study which is the first of its kind to be approved by the state’s Department of Consumer Protection (DCP) medical…

TuesdayNov 12, 2019 4:20 pm

420 with CNW – Study Finds That Marijuana Use Disorder is Declining

According to a new study, the number of people diagnosed with cannabis use disorder (CUD) is not increasing. The results contradict the expectation of public health experts who thought that due to the legalization of marijuana, more people would consume more and more weed. The incidence of CUD is decreasing, and this could be attributed to the growing number of states that have made marijuana legal. According to the report, between the years 2002 and 2016, the frequency of CUD decreased significantly across people of all ages. The decrease in cannabis dependence was noticed in adolescents, and young adults and…

TuesdayNov 12, 2019 10:28 am

LiveWire Ergogenics Inc. (LVVV) Banking on SAFE Banking Act to Pass and Strengthen Company’s Position in Cannabis Space

Passage of SAFE Banking Act will open access to financial services for the multibillion-dollar marijuana industry LiveWire focusing efforts on expanding operations on path to a vertically integrated Company Acquisition of Estrella Ranch property, the LiveWire “Estate Grown Weedery” is “biggest accomplishment yet” LiveWire Ergogenics Inc. (OTC: LVVV), a forward-thinking company involved in the acquisition, licensing and management of fully compliant turnkey facilities engaged in the production of high-quality cannabis-based products and services in California, is closely watching the progress of the SAFE Banking Act, which once passed on the Senate, would allow banks and credit unions to provide financial…

TuesdayNov 12, 2019 4:20 am

420 with CNW – Florida House Panel Turns to Oregon for Lessons on Recreational Marijuana

There is a strong possibility of putting recreational marijuana legalization on the 2020 ballot in Florida and this has prompted the House panel to turn to Oregon to learn about the economic, environmental, and other changes that have occurred since the state legalized recreational marijuana in 2015. The executive director of the Oregon-Idaho High-Intensity Drug Trafficking Area, Chris Gibson, told the House panel (House Health & Human Services Committee) that there has been an increase in tax revenue. The state has also experienced a rise in illicit use of drugs and that currently, Oregon is dealing with marijuana overproduction. Gibson…

MondayNov 11, 2019 4:20 pm

420 with CNW – Recreational Marijuana Could Be Available in Michigan Sooner Than Expected

Potential marijuana businesses in Michigan are eagerly waiting for recreational licenses to be processed. This will allow them to start cultivating, processing, and selling legal pot to the residents. Depending on the time the businesses are licensed, the current rules, and the duration of the growth cycle, it is estimated that recreational marijuana is likely to be available on the market in March or April. The state’s recreational marijuana law is blind to any other existing marijuana products, so the recreational marijuana market must begin from zero unless the Marijuana Regulatory Agency Director, Andrew Brisbo, allows retailers to open their…

MondayNov 11, 2019 2:13 pm

Fire & Flower Holdings Corp. (TSX: FAF) (OTC: FFLWF) Maximizing Cannabis Experience via Education and Customization

Owns or has interests in 24 cannabis retail stores throughout Canada, 65 stores expected by July 2020 Creates personalized shopping experience through Hifyre platform, new Spark Perks membership program Looking to promising markets for international expansion Fire & Flower Holdings Corp. (TSX: FAF) (OTC: FFLWF) is a leading, purpose-built, independent, adult-use cannabis retailer that provides a guided and informed experience that challenges preexisting cannabis stereotypes. Fire & Flower owns or has interests in cannabis retail-store licenses in the Canadian provinces of Alberta, Saskatchewan, Manitoba, and Ontario as well as the Yukon territory. The company currently has 24 retail stores operating…

MondayNov 11, 2019 12:36 pm

BevCanna Enterprises Inc. (CSE: BEV) (OTC: BVNNF) (FRA: 7BC) Enters Billion-Dollar Vape Market, Brings Bloom Brand to Canada

BEV partners with Capna; signs LOI to manufacture, possess and sell vape products in Canada Company to sell products legally under license from Health Canada Cannabis, CBD and hemp-infused drinks market estimated to hit $1.4 billion by 2024 in the U.S. BevCanna Enterprises Inc. (CSE: BEV) (OTC: BVNNF) (FRA: 7BC) has signed an LOI with high-profile cannabis operator Capna Intellectual Inc., the production partner of Bloom, to bring the Bloom brand, including its vaping products, to Canada. Both BEV and Capna are working towards a definitive agreement calling for BEV to manufacture, possess and sell Bloom cannabis products, such as…

MondayNov 11, 2019 4:20 am

420 with CNW – Canadian Study Finds That Marijuana Could Treat PTSD-Induced Depression

People with PTSD (post-traumatic stress disorder) often suffer from depression and bouts of suicidal ideations. Research shows these people can treat this depression with marijuana. The University of British Columbia and the B.C Centre of Substance use (BCCSU) conducted a study that shows that pot could be used to treat PTSD-induced depression. The study researchers analyzed data of 24,000 Canadians from Statistics Canada. Their findings were published in the Journal of Psychopharmacology. The researchers found that people who used marijuana did not suffer from PTSD-induced depression, but those who did not consume marijuana were found to have significant episodes of…

News and publishing service for cannabis related companies

Contact us: 303.498.7722

Month: November 2019